CLINICAL OBSTETRICS AND GYNECOLOGY临床妇产科

CLINICAL OBSTETRICS AND GYNECOLOGY(英文缩写 CLIN OBSTET GYNECOL),ISSN 0009-9201,eISSN 1532-5520,中文译名:临床妇产科 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
1.500
JCR 分区
Q3
CAS 分区
B4
近一年发文量
96
本站 PubMed 收录统计

发文量统计区间:2025-11-01 至 2026-10-31,按本站收录文献的发表日期统计。

ISSN: 0009-9201 · eISSN: 1532-5520 · 缩写: CLIN OBSTET GYNECOL ·中文: 临床妇产科

期刊介绍

选择期刊介绍栏目

期刊简介

《Clinical Obstetrics and Gynecology》是一本以临床实践为导向的综述性期刊,每期围绕妇产科领域的一个核心主题展开,邀请专家撰写系统而实用的文章。内容覆盖产科、妇科、生殖内分泌、妇科肿瘤及母胎医学等方向,强调将研究证据转化为临床决策。读者群主要为妇产科临床医生、住院医师、医学生及相关护理人员,适合希望快速掌握某一专题最新进展的从业者。

研究方向

主要方向包括母胎医学、普通产科、妇科手术、生殖内分泌与不孕、妇科肿瘤、泌尿妇科及女性预防保健。论文类型以特邀综述、专题合集和临床实践指南解读为主,也包含少量病例讨论和观点性文章。选题通常聚焦于诊断路径、治疗选择、手术技术及围产期管理中的争议与共识。

期刊特色

研究取向偏重临床实用性和教育性,文章多由领域内专家撰写,结构清晰、图文并茂,便于直接指导诊疗。论文特点在于系统梳理某一主题的现有证据,并给出可操作的建议,而非发表原始研究。适合临床医生、住院医师、专科培训生及关注妇产科进展的全科医生阅读,也适合作为教学和继续教育的参考资料。

投稿难度

投稿难度中等偏上,但并非仅由分区决定。该刊以约稿和专题组稿为主,自由投稿的接受率相对有限,且对选题的临床相关性和综述深度要求较高。建议在投稿前先了解近期专题方向,确保内容契合期刊定位;若为原创研究,需评估是否适合该刊的综述型风格。准备时应注重文献整合的全面性、观点的平衡性以及临床建议的可行性。

历年影响因子趋势

JCR 数据年份影响因子JCR 分区
20211.966Q4
20221.500Q4
20231.400Q3
20241.400Q3
20251.500Q3

CLINICAL OBSTETRICS AND GYNECOLOGY 最新收录文献

  1. JCR分区: Q3 CAS分区: B4 影响因子: 1.5

    1. Contraceptive Counseling and Options in Patients With Cardiovascular Disease.

    1. 心血管疾病患者的避孕咨询与选择
    作者:
    Eleanor Christenson, Lindsay Panah
    日期:
    2026-09-15

    Cardiovascular disease is among the leading causes of maternal morbidity and mortality in the United States. In patients with underlying cardiovascular disease, safe and effective contraception can prevent the poor outcomes that are associated with unplanned pregnancy. There are many options for contraception, and it is important to understand how certain cardiovascular diseases impact contraceptive recommendations. This review aims to summarize the options for contraception, emphasize the importance of patient-centered contraceptive counseling, and describe the risks and benefits of each method in patients with different types of cardiovascular disease.

  2. JCR分区: Q3 CAS分区: B4 影响因子: 1.5

    2. Argument in Favor of Reporting Adult-onset Conditions in Prenatal Diagnosis.

    2. 支持在产前诊断中报告成人发病疾病的论点
    作者:
    Brittany Arditi, Caitlin D Baptiste, Jessica L Giordano, Ronald J Wapner
    日期:
    2026-09-10

    Prenatal genomic sequencing can detect far more than clinicians conventionally report. Whether adult-onset conditions diagnosed in the fetus should be disclosed prenatally remains debated, and most laboratories and guidelines restrict reporting to childhood-onset disease. We argue that this restriction is not supported by available evidence. Prospective parents consistently elect to receive adult-onset findings, most often to plan for a child's future health. Pediatric and newborn sequencing studies have not demonstrated the psychological, relational, or developmental harms critics anticipated, and pregnancy offers an unmatched opportunity to reach an otherwise unscreened population. Policy should be guided by informed consent and patient autonomy.

  3. JCR分区: Q3 CAS分区: B4 影响因子: 1.5

    3. Against: Treating All Pregnant Women With Aspirin to Prevent Pre-eclampsia.

    3. 反对:对所有孕妇使用阿司匹林以预防先兆子痫
    作者:
    Madeleine P Kendall, Fabricio da Silva Costa, Yinka Oyelese, Daniel L Rolnik
    日期:
    2026-08-25

    Pre-eclampsia is a pregnancy disorder associated with substantial maternal and perinatal morbidity and mortality worldwide. Low-dose aspirin initiated during the first trimester can reduce the risk of preterm pre-eclampsia, leading some to advocate universal prophylaxis during pregnancy. Although simple in principle, this approach would unnecessarily expose many low-risk women to treatment while providing limited absolute benefit. Moreover, the effectiveness of aspirin depends on treatment adherence, which may be reduced without individualized risk assessment. Current evidence supports targeted aspirin prophylaxis following first-trimester risk stratification rather than universal treatment, an approach that has not been evaluated in adequately powered randomized trials.

  4. JCR分区: Q3 CAS分区: B4 影响因子: 1.5

    4. Anesthetic and Analgesic Considerations in Pregnant Patients With Cardiac Disease.

    4. 心脏病孕妇的麻醉与镇痛考虑
    作者:
    Afif Kraitem, Kaitlyn A Brennan
    日期:
    2026-08-21

    Successful anesthetic management of pregnant patients with cardiac disease requires an understanding of both maternal physiology and alterations induced by labor analgesia and anesthesia for cesarean delivery. This review provides an overview of physiological changes of pregnancy pertinent to obstetric anesthesiology in regard to patients with cardiac disease, including modifications to labor analgesic techniques, indications for additional monitoring, and both regional anesthetic and general anesthetic management of complex cardiac patients for cesarean delivery. The importance of a comprehensive pregnancy heart team cannot be overstated, especially when managing patients with very high-risk cardiac comorbidities.

  5. JCR分区: Q3 CAS分区: B4 影响因子: 1.5

    5. Routine Hospitalization for Vasa Previa in the Third Trimester: Evidence Review and Clinical Implications.

    作者:
    Andrei Rebarber
    日期:
    2026-08-17

    Vasa previa is a life-threatening pregnancy complication in which unprotected fetal vessels traverse or are adjacent to the internal cervical os. This condition puts the fetus at risk of death if these vessels rupture in labor. Although prenatal diagnosis has improved our ability to identify these cases, optimal prenatal management remains controversial. Routine hospitalization at 30 to 34 weeks has been advocated but outpatient management achieves equivalent perinatal outcomes in recent publications. Routine hospitalization may be excessive and potentially wrought with maternal complications, therefore, an individualized, risk-stratified approach determining hospitalization may be warranted in light of more recent literature.

  6. JCR分区: Q3 CAS分区: B4 影响因子: 1.5

    6. When Experts Disagree: Contemporary Controversies in Maternal-Fetal Medicine.

    6. 当专家意见相左:母胎医学中的当代争议
    作者:
    Yinka Oyelese, Yalda Afshar
    日期:
    2026-08-12

    该文献暂无摘要。

  7. JCR分区: Q3 CAS分区: B4 影响因子: 1.5

    7. Should Maternal-Fetal Medicine Physicians Staff Labor Floors? Or: Obstetricians We Were, Obstetricians We Are, and Obstetricians We Should Be.

    7. 母胎医学医师是否应值守产房?或者:我们曾经是产科医生,我们现在是产科医生,我们应该成为产科医生
    作者:
    Steven J Ralston
    日期:
    2026-08-10

    [中文摘要] 母胎医学专家面临着强烈的经济激励,促使他们远离产房及分娩患者的管理工作。然而,医疗体系和医学教育均受益于母胎医学专家参与产科护理的各个方面,他们在产房中的在场将惠及患者、学习者以及他们自身。

    [英文摘要] Maternal-fetal medicine specialists face strong financial incentives to absent themselves from labor floors and the management of laboring patients. Nevertheless, health care systems and medical education benefit from MFM involvement in every aspect of obstetrical care, and their presence on the labor floor will benefit patients, learners, and themselves.

  8. JCR分区: Q3 CAS分区: B4 影响因子: 1.5

    8. Maternal-Fetal Medicine Specialists and Routine Vaginal Birth: Why Subspecialty Resources Should Be Reserved for High-Risk Care.

    8. 母胎医学专家与常规阴道分娩:为何应将亚专科资源保留用于高风险护理
    作者:
    Jeffrey D Sperling
    日期:
    2026-07-27

    [中文摘要] 母胎医学(MFM)专家是经过高度培训的亚专科医生,其专长在于管理复杂妊娠。本文反对母胎医学专家常规参与低风险分娩过程,重点关注成本效率低下、劳动力短缺、产科护理荒漠、公平性问题以及与其他提供初级保健的亚专科医生的比较。本文还强调了产科住院医师框架及与助产士协作护理模式作为可持续替代方案的优势。

    [英文摘要] Maternal-fetal medicine (MFM) specialists are highly trained subspecialists whose expertise lies in managing complex pregnancies. This paper argues against the routine involvement of MFMs in low-risk labor and delivery, focusing on cost inefficiencies, workforce shortages, maternity care deserts, equity concerns, and comparisons to other subspecialists providing primary care. It also highlights the benefits of obstetric hospitalist frameworks and collaborative care models with midwives as sustainable alternatives.

  9. JCR分区: Q3 CAS分区: B4 影响因子: 1.5
  10. JCR分区: Q3 CAS分区: B4 影响因子: 1.5

在 CLINICAL OBSTETRICS AND GYNECOLOGY 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊